|
|
|
|
| LEADER |
01000caa a2200265 4500 |
| 001 |
OLC1992681724 |
| 003 |
DE-627 |
| 005 |
20230514133126.0 |
| 007 |
tu |
| 008 |
170512s2017 xx ||||| 00| ||eng c |
| 024 |
7 |
|
|a 10.1016/j.jinf.2017.02.005
|2 doi
|
| 028 |
5 |
2 |
|a PQ20170501
|
| 035 |
|
|
|a (DE-627)OLC1992681724
|
| 035 |
|
|
|a (DE-599)GBVOLC1992681724
|
| 035 |
|
|
|a (PRQ)c679-9ae5d945a9e0629d129541013f77f6fdd8eeb77b2cbbae09cff6f60bcab394680
|
| 035 |
|
|
|a (KEY)0093435620170000000000000000threeyearevaluationofxpertmtbrifinalowprevalencetu
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 082 |
0 |
4 |
|a 610
|q DE-600
|
| 084 |
|
|
|a XA 54270
|q AVZ
|2 rvk
|
| 084 |
|
|
|a 44.00
|2 bkl
|
| 100 |
1 |
|
|a Parcell, Benjamin J
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Three year evaluation of Xpert MTB/RIF in a low prevalence tuberculosis setting: A Scottish perspective
|
| 264 |
|
1 |
|c 2017
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 700 |
1 |
|
|a Jarchow-MacDonald, Anna
|4 oth
|
| 700 |
1 |
|
|a Seagar, Amie-Louise
|4 oth
|
| 700 |
1 |
|
|a Laurenson, Ian
|4 oth
|
| 700 |
1 |
|
|a Prescott, Gordon J
|4 oth
|
| 700 |
1 |
|
|a Lockhart, Michael
|4 oth
|
| 773 |
0 |
8 |
|i Enthalten in
|t Journal of infection
|d Amsterdam [u.a.] : Elsevier, 1979
|g (2017)
|w (DE-627)167181750
|w (DE-600)424417-5
|w (DE-576)015568423
|x 0163-4453
|7 nnns
|
| 773 |
1 |
8 |
|g year:2017
|
| 856 |
4 |
1 |
|u http://dx.doi.org/10.1016/j.jinf.2017.02.005
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_OLC
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 912 |
|
|
|a SSG-OLC-DE-84
|
| 912 |
|
|
|a GBV_ILN_4219
|
| 936 |
r |
v |
|a XA 54270
|
| 936 |
b |
k |
|a 44.00
|q AVZ
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|j 2017
|
